Ziprasidone Mesylate Injection, Powder, Lyophilized, For Solution
Product Images NDC 68083-340

View Photos of Packaging, Regulatory Labels, and Product Appearance

Product Visual Gallery

This gallery contains 3 technical images submitted to the FDA as part of the official labeling for Ziprasidone Mesylate (NDC 68083-340). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Gland Pharma Limited, these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

Product Images & Figures Index

FDA Label Image

Zipra Spl Carton Label

Zipra Spl Carton Label
This is a drug information insert for a medication called Ziprasidone Mesylate for Injection to be administered through intramuscular route only. The medication comes in a single-dose vial and should be reconstituted with sterile water for injection. One millilitre of reconstituted medication contains 20 mg ziprasidone mesylate and 4.7 mg methanesulfonic acid. It comes with instructions for use, dosage, storage, and shelf-life. The medication must be protected from light and has to be stored under specific temperature conditions dictated by USP (United States Pharmacopeia). It is manufactured in India by Gland Pharma Limited.*
FDA Label Image

Zipra Spl Container Label

Zipra Spl Container Label
This is a description of Ziprasidone Mesylate for Injection. It is a sterile, single-dose vial containing Ziprasidone Mesylate for use only through intramuscular administration. The product is only available through a prescription. Each mL, upon reconstitution contains Ziprasidone Mesylate equivalent to 20mg of Ziprasidone, and 4.7 mg of methanesulfonic acid solubilized by 294 mg of sulfobutylether B-cyclodextrin sodium. The proper storage temperature is from 20°C to 25°C (68°F to 77°F) to be kept in dry form and protected from light. The manufacturer has provided specific instructions, warnings, and precautions, which are included in the accompanying information.*
FDA Label Image

Zipra Spl Structure

Zipra Spl Structure

* These product label images have been analyzed using experimental machine learning. Please verify findings with the primary label text.